168 related articles for article (PubMed ID: 19101960)
1. Cytotoxic rhodium(III) and iridium(III) polypyridyl complexes: structure-activity relationships, antileukemic activity, and apoptosis induction.
Dobroschke M; Geldmacher Y; Ott I; Harlos M; Kater L; Wagner L; Gust R; Sheldrick WS; Prokop A
ChemMedChem; 2009 Feb; 4(2):177-87. PubMed ID: 19101960
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS(3).
Bieda R; Ott I; Dobroschke M; Prokop A; Gust R; Sheldrick WS
J Inorg Biochem; 2009 May; 103(5):698-708. PubMed ID: 19243835
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cellular uptake and structure-activity relationships for potent cytotoxic trichloridoiridium(III) polypyridyl complexes.
Scharwitz MA; Ott I; Gust R; Kromm A; Sheldrick WS
J Inorg Biochem; 2008 Aug; 102(8):1623-30. PubMed ID: 18472166
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity, and structure-activity relationships for potent cytotoxic rhodium(III) polypyridyl complexes.
Harlos M; Ott I; Gust R; Alborzinia H; Wölfl S; Kromm A; Sheldrick WS
J Med Chem; 2008 Jul; 51(13):3924-33. PubMed ID: 18543901
[TBL] [Abstract][Full Text] [Related]
5. Cell-selective, apoptosis-inducing rhodium(III) crown thiaether complexes.
Bieda R; Dobroschke M; Triller A; Ott I; Spehr M; Gust R; Prokop A; Sheldrick WS
ChemMedChem; 2010 Jul; 5(7):1123-33. PubMed ID: 20572280
[TBL] [Abstract][Full Text] [Related]
6. Cellular selectivity and biological impact of cytotoxic rhodium(III) and iridium(III) complexes containing methyl-substituted phenanthroline ligands.
Geldmacher Y; Kitanovic I; Alborzinia H; Bergerhoff K; Rubbiani R; Wefelmeier P; Prokop A; Gust R; Ott I; Wölfl S; Sheldrick WS
ChemMedChem; 2011 Mar; 6(3):429-39. PubMed ID: 21337523
[TBL] [Abstract][Full Text] [Related]
7. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.
Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS
J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751
[TBL] [Abstract][Full Text] [Related]
8. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure and antitumor activity of [RhCl3(N-N)(DMSO)] polypyridyl complexes.
Sliwińska U; Pruchnik FP; Pelińska I; Ułaszewski S; Wilczok A; Zajdel A
J Inorg Biochem; 2008 Oct; 102(10):1947-51. PubMed ID: 18718669
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
11. Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts.
Geldmacher Y; Splith K; Kitanovic I; Alborzinia H; Can S; Rubbiani R; Nazif MA; Wefelmeier P; Prokop A; Ott I; Wölfl S; Neundorf I; Sheldrick WS
J Biol Inorg Chem; 2012 Apr; 17(4):631-46. PubMed ID: 22358334
[TBL] [Abstract][Full Text] [Related]
12. Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes.
Bieda R; Kitanovic I; Alborzinia H; Meyer A; Ott I; Wölfl S; Sheldrick WS
Biometals; 2011 Aug; 24(4):645-61. PubMed ID: 21274738
[TBL] [Abstract][Full Text] [Related]
13. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
[TBL] [Abstract][Full Text] [Related]
14. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and cellular impact of dinuclear organoiridium DNA intercalators and nucleases with long rigid bridging ligands.
Nazif MA; Rubbiani R; Alborzinia H; Kitanovic I; Wölfl S; Ott I; Sheldrick WS
Dalton Trans; 2012 May; 41(18):5587-98. PubMed ID: 22415580
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents.
Kasper C; Alborzinia H; Can S; Kitanovic I; Meyer A; Geldmacher Y; Oleszak M; Ott I; Wölfl S; Sheldrick WS
J Inorg Biochem; 2012 Jan; 106(1):126-33. PubMed ID: 22115828
[TBL] [Abstract][Full Text] [Related]
17. Probing the mer- to fac-isomerization of tris-cyclometallated homo- and heteroleptic (C,N)3 iridium(III) complexes.
McDonald AR; Lutz M; von Chrzanowski LS; van Klink GP; Spek AL; van Koten G
Inorg Chem; 2008 Aug; 47(15):6681-91. PubMed ID: 18588287
[TBL] [Abstract][Full Text] [Related]
18. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
[TBL] [Abstract][Full Text] [Related]
19. Furano-sesquiterpene from soft coral, Sinularia kavarittiensis: induces apoptosis via the mitochondrial-mediated caspase-dependent pathway in THP-1, leukemia cell line.
Arepalli SK; Sridhar V; Venkateswara Rao J; Kavin Kennady P; Venkateswarlu Y
Apoptosis; 2009 May; 14(5):729-40. PubMed ID: 19283488
[TBL] [Abstract][Full Text] [Related]
20. Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.
Ruiz J; Rodríguez V; Cutillas N; Samper KG; Capdevila M; Palacios Ò; Espinosa A
Dalton Trans; 2012 Nov; 41(41):12847-56. PubMed ID: 22983366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
